Oxnard, Geoffrey R.
Eli Lilly and Company,
United States
2025 Rank: 20982
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Dentistry
Rank in SubField 1: 622 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 20982 | 20851 |
| Total Cites | 2350 | 2552 |
| H-index | 25 | 26 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 5 | 5 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 297 | 305 |
| Number of Single+First+Last Authored Papers | 78 | 78 |
| Total Cites to Single+First+Last Authored Papers | 723 | 764 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1706 | 1803 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.42 |
| Self-Citation Percentage |
7.92%
|
|
Oxnard, Geoffrey R.
Foundation Medicine, Inc.,
United States
2024 Rank: 19183
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 623 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 19183 | 19498 |
| Total Cites | 2288 | 2514 |
| H-index | 23 | 24 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 345 | 360 |
| Number of Single+First+Last Authored Papers | 77 | 77 |
| Total Cites to Single+First+Last Authored Papers | 822 | 861 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1560 | 1658 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.52 |
| Self-Citation Percentage |
8.99%
|
|
Oxnard, Geoffrey R.
Foundation Medicine, Inc.,
United States
2023 Rank: 16648
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 607 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 16648 | 16908 |
| Total Cites | 2434 | 2623 |
| H-index | 23 | 25 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 6 | 6 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 407 | 425 |
| Number of Single+First+Last Authored Papers | 73 | 73 |
| Total Cites to Single+First+Last Authored Papers | 957 | 1020 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1578 | 1678 |
| Ratio of Total Citations to Distinct Citing Papers | 1.54 | 1.56 |
| Self-Citation Percentage |
7.21%
|
|
Oxnard, Geoffrey R.
Foundation Medicine, Inc.,
United States
2022 Rank: 10217
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 396 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 10217 | 10719 |
| Total Cites | 2377 | 2621 |
| H-index | 26 | 27 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 10 | 10 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 479 | 510 |
| Number of Single+First+Last Authored Papers | 72 | 72 |
| Total Cites to Single+First+Last Authored Papers | 1071 | 1146 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1561 | 1674 |
| Ratio of Total Citations to Distinct Citing Papers | 1.52 | 1.57 |
| Self-Citation Percentage |
9.31%
|
|
Oxnard, Geoffrey R.
Dana-Farber Cancer Institute,
United States
2021 Rank: 13344
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 486 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13344 | 14129 |
| Total Cites | 2918 | 3140 |
| H-index | 29 | 31 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 13 | 13 |
| Number of Single+First Authored Papers | 33 | 33 |
| Total Cites to Single+First Authored Papers | 689 | 726 |
| Number of Single+First+Last Authored Papers | 64 | 64 |
| Total Cites to Single+First+Last Authored Papers | 1399 | 1487 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2023 | 2121 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.48 |
| Self-Citation Percentage |
7.07%
|
|
Oxnard, Geoffrey R.
Dana-Farber Cancer Institute,
United States
2020 Rank: 13078
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pathology
Rank in SubField 1: 472 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 13078 | 13903 |
| Total Cites | 1919 | 2044 |
| H-index | 23 | 24 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 12 | 13 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 536 | 562 |
| Number of Single+First+Last Authored Papers | 60 | 60 |
| Total Cites to Single+First+Last Authored Papers | 1075 | 1151 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1399 | 1469 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.39 |
| Self-Citation Percentage |
6.12%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.